Form 4: RxSight Director Sells Shares Under 10b5-1 Trading Plan

RxSight director Shweta Maniar sold 3,782 shares of common stock at $45.88 per share on November 26, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Shweta Maniar, a director at RxSight, Inc., sold 3,782 shares of common stock on November 26, 2024.
• The sale was executed at a price of $45.88 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan established on August 22, 2024.
• Following the sale, Ms. Maniar directly owns 10,902 shares of RxSight common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to a pre-planned stock sale by a director. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider trading activity. It is common for directors to use 10b5-1 plans to sell shares to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among corporate insiders to manage their stock sales and avoid potential conflicts of interest.
• Many directors and officers at publicly traded companies use similar plans to sell shares over time.
• The volume of shares sold is relatively small compared to the total outstanding shares of the company, suggesting this is a routine transaction.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to have a significant effect due to the pre-planned nature of the transaction.

Key Dates

Keywords

Form 4, insider trading, stock sale, Rule 10b5-1, RxSight, director, equity securities